| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/06/2014 | US8716455 Genetic products differentially expressed in tumors and use thereof |
| 05/06/2014 | US8716454 Solid compositions |
| 05/06/2014 | US8716448 Coagulation factor VII compositions and methods of making and using same |
| 05/06/2014 | US8716446 Biopolymer conjugates comprising an interleukin-11 analog |
| 05/06/2014 | US8716445 Compositions comprising signal peptide-containing proteins |
| 05/06/2014 | US8716441 Ubiquitin binding polypeptides |
| 05/06/2014 | US8716439 Method of producing peptide |
| 05/06/2014 | US8716438 Matricryptic ECM peptides for tissue reconstruction |
| 05/06/2014 | US8716437 Identification of toxin ligands |
| 05/06/2014 | US8716344 Class- and isoform-specific HDAC inhibitors and uses thereof |
| 05/06/2014 | US8716301 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation |
| 05/06/2014 | US8716247 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/06/2014 | US8716246 Azuvirin peptides |
| 05/06/2014 | US8716245 Tissue protective peptides and uses thereof |
| 05/06/2014 | US8716244 Diaminooxidase-containing pharmaceutical compositions |
| 05/06/2014 | US8716243 Methods of effecting Wnt signaling through Dkk structural analysis |
| 05/06/2014 | US8716242 β-hairpin peptidomimetics |
| 05/06/2014 | US8716241 ApoIII and the treatment and diagnosis of diabetes |
| 05/06/2014 | US8716240 Erythropoietin: remodeling and glycoconjugation of erythropoietin |
| 05/06/2014 | US8716239 Granulocyte colony stimulating factor: remodeling and glycoconjugation G-CSF |
| 05/06/2014 | US8716238 Cyclosporin derivatives for treating ocular and dermal diseases and conditions |
| 05/06/2014 | US8716237 Methods for the treatment or prevention of hemorrhagic conditions |
| 05/06/2014 | US8716236 Inhibitors of IAP |
| 05/06/2014 | US8716235 Method for inhibiting metastasis by using anti-CCL3 antibodies |
| 05/06/2014 | US8716234 Cytotoxins comprising modified bouganin toxin for the treatment of cancer |
| 05/06/2014 | US8716232 Use of endostatin peptides for the treatment of fibrosis |
| 05/06/2014 | US8716228 GPR54 agonists or antagonists for treatment of diseases presenting behavioral abnormalities |
| 05/06/2014 | US8716227 Graft prosthesis, materials and methods |
| 05/06/2014 | US8716226 3,5 phenyl-substituted beta amino acid derivatives as integrin antagonists |
| 05/06/2014 | US8716225 Kallikrein inhibitors and anti-thrombolytic agents and uses thereof |
| 05/06/2014 | US8716224 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| 05/06/2014 | US8716223 Small survival-promoting/immunomodulatory peptide for treatment of brain damage, neurodegenerative disorders, and inflammatory disorders |
| 05/06/2014 | US8716222 Methods and compositions for promoting organ development |
| 05/06/2014 | US8716221 Modified exendins and uses thereof |
| 05/06/2014 | US8716220 Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amyloid beta |
| 05/06/2014 | US8716218 Extracellular histones as biomarkers for prognosis and molecular targets for therapy |
| 05/06/2014 | US8716217 Polyglutamic acids functionalized by cationic groups and hydrophobic groups and applications thereof, in particular therapeutic applications thereof |
| 05/06/2014 | US8716216 Human immunosuppressive protein |
| 05/06/2014 | US8716215 Method of treating or preventing tissue deterioration, injury or damage due to a neuro-, muscular- or neuro-muscular-degenerative disease, or restore tissue adversely affected by said disease |
| 05/06/2014 | US8716012 Alpha thymosin peptides as vaccine enhancers |
| 05/06/2014 | US8715996 Beta-glucosidase variant enzymes and related polynucleotides |
| 05/06/2014 | US8715995 Polypeptides having beta-glucosidase activity and beta-xylosidase activity and polynucleotides encoding same |
| 05/06/2014 | US8715994 Polypeptides having beta-glucosidase and beta-xylosidase activity and polynucleotides encoding same |
| 05/06/2014 | US8715986 Stereoisomer peptides, ligand-targeted multi- stereoisomer peptide polymer conjugates, and uses thereof |
| 05/06/2014 | US8715968 Methods and reagents for modulating cholesterol levels |
| 05/06/2014 | US8715957 Microorganisms and methods for the biosynthesis of aromatics, 2,4-pentadienoate and 1,3-butadiene |
| 05/06/2014 | US8715922 Virus causing respiratory tract illness in susceptible mammals |
| 05/06/2014 | US8715742 Method for reducing weight in a subject |
| 05/06/2014 | US8715733 Enhanced adipose tissue |
| 05/06/2014 | US8715718 Extracellular matrix production from nanoscale substrate |
| 05/06/2014 | US8715698 Truncated secretory aspartyl proteinase 2 |
| 05/06/2014 | US8715695 Polypeptide fragments of the hepatitis E virus, the vaccine composition comprising said fragments and the diagnostic kits |
| 05/06/2014 | US8715684 Peptides inducing a CD4i conformation in HIV gp120 while retaining vacant CD4 binding site |
| 05/06/2014 | US8715683 RANK ligand polypeptides |
| 05/06/2014 | US8715682 Means for the inhibition of anti-beta1-adrenergic receptor antibodies |
| 05/06/2014 | US8715680 HLA peptide therapy |
| 05/06/2014 | US8715676 Production and uses of type I ribosome inactivating proteins |
| 05/06/2014 | US8715675 Vascular targets for detecting, imaging and treating neoplasia or neovasculature |
| 05/06/2014 | US8715667 Methods of treating patients having TLR3-positive cancer |
| 05/06/2014 | US8715661 Methods and compositions for increasing arylsulfatase A activity in the CNS |
| 05/06/2014 | US8715658 Methods for treating conditions mediated by the inflammatory cytokine cascade using GAPDH inhibitors |
| 05/06/2014 | US8715654 Methods of modulating the negative chemotaxis of immune cells |
| 05/06/2014 | US8715649 Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activity |
| 05/06/2014 | US8715647 Enzyme feed additive and animal feed including it |
| 05/06/2014 | US8715645 Viral vectors encoding apoptosis-inducing proteins and methods for making and using the same |
| 05/06/2014 | US8715638 Ethenyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| 05/06/2014 | US8715637 Interferon-lambda 1 polypeptides |
| 05/06/2014 | US8715626 Cosmetic for hair containing co-modified organopolysiloxane |
| 05/06/2014 | US8715620 Treatment of asthma in mammals with clostridia neurotoxins |
| 05/06/2014 | US8715619 Compositions and methods for treating haematological proliferative disorders of myeloid origin |
| 05/06/2014 | CA2743731C Method of modulating the proliferation of medullary thyroid carcinoma cells |
| 05/06/2014 | CA2681294C Method for producing high-purity soluble thrombomodulin |
| 05/06/2014 | CA2642389C Use of tpo peptide compounds and pharmaceutical compositions in the treatment of anemia |
| 05/06/2014 | CA2616345C Novel milk protein fractions and use thereof for preventing or treating chronic inflammatory diseases |
| 05/06/2014 | CA2612937C Concentrated protein lyophilates, methods, and uses |
| 05/06/2014 | CA2585638C Aminopyridine derivatives having aurora a selective inhibitory action |
| 05/06/2014 | CA2518262C Uses of il-23 agonists and antagonists; related reagents |
| 05/06/2014 | CA2514474C Freeze-dried fibrin matrices and methods for preparation thereof |
| 05/06/2014 | CA2511838C Uses of mammalian cytokine; related reagents |
| 05/06/2014 | CA2488059C Non-polymeric hematopoietic cell clots for delivery of active agents |
| 05/06/2014 | CA2475446C Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
| 05/06/2014 | CA2435982C Medicaments |
| 05/06/2014 | CA2401327C Nucleic acid formulations comprising poly-amino acids for gene delivery and methods of use |
| 05/06/2014 | CA2287911C Apo-2 receptor |
| 05/01/2014 | WO2014066916A2 Compositions and methods for safe treatment of rhinitis |
| 05/01/2014 | WO2014066808A1 Insulin-mimetic local therapeutic adjuncts for enhancing spinal fusion |
| 05/01/2014 | WO2014066686A1 Brain targets for neurotrophic factors to treat neurodegenerative disease |
| 05/01/2014 | WO2014066681A1 Modified release formulations for oprozomib |
| 05/01/2014 | WO2014066622A2 Use of collagenase to treat glaucoma |
| 05/01/2014 | WO2014066527A2 Il-15r alpha forms, cells expressing il-15r alpha forms, and therapeutic uses of il-15r alpha and il-15/il-15r alpha complexes |
| 05/01/2014 | WO2014066507A1 Allogeneic autophagosome-enriched composition for the treatment of disease |
| 05/01/2014 | WO2014066443A1 Gm-csf and il-4 conjugates, compositions, and methods related thereto |
| 05/01/2014 | WO2014066419A2 Methods for reducing risks associated with heart failure and factors associated therewith |
| 05/01/2014 | WO2014066392A2 Compositions and methods for regulating arterial tone |
| 05/01/2014 | WO2014066162A1 Recombinant mycobacterium avium subsp. paratuberculosis proteins induce immunity and protect against infection |
| 05/01/2014 | WO2014065863A1 Compositions and methods for promoting collagen-crosslinking |
| 05/01/2014 | WO2014065669A1 Methods of treatment and diagnosis for cognitive decline and memory impairment |
| 05/01/2014 | WO2014065606A1 Agent for treating nerve disease, comprising osmotin composition and inhibitor for inhibiting expression or activity of gaba b receptor proteins |
| 05/01/2014 | WO2014065348A1 Novel method for treating spinal cord injury using hmgb1 fragment |
| 05/01/2014 | WO2014065347A1 Novel method for treating cardiac infarction using hmgb1 fragment |